Shares of Stryker rose after the medical technology company said it commercially launched its Mako robotic power system for total knee replacement procedures.

The stock was up 5.1% to $332.99 in recent trading, but fell 5.3% since the start of the year.

Stryker said the system would provide surgeons with an intuitive handheld robotic experience, introducing its technology to a new customer segment of the orthopaedic market.

Vice President of Stryker's Mako and Enabling Technologies business Keith Evans said customer response during the limited market release has been exceptionally strong.

The new technology is equipped with Stryker's patented active adjustment technology and provides a familiar cutting experience for surgeons interested in adopting robotic technology while integrating easily into their existing surgical workflows, the company said.

Write to Grace Yoon at grace.yoon@wsj.com

(END) Dow Jones Newswires

July 16, 2026 10:59 ET (14:59 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.